Literature DB >> 16920486

The mast cell mediator PGD2 suppresses IL-12 release by dendritic cells leading to Th2 polarized immune responses in vivo.

Gabi Theiner1, André Gessner, Manfred B Lutz.   

Abstract

Dendritic cells (DC) and mast cells (MC) are colocalized in superficial organs such as the skin. Both cell types recognize and respond to pathogens. DC capture and transport antigens to the draining lymph node for CD4+ T cell priming and T helper 1 (Th1) or Th2 polarization. As MC are mainly associated with Th2 responses, DC-MC interactions may favor Th2 priming by DC. Here, we show the role of different MC mediators on IL-12 and IL-10 production by DC. While histamine, leukotriene C4, heparin and chondroitin sulfate A had little and unspecific effects on the cytokine production, prostaglandin D2 (PGD2) downregulated IL-10, IL-12p70 and p40. After subcutaneous (s.c.) injection of ovalbumin (OVA)-loaded, lipopolysaccharide (LPS)-matured DC into Th1-prone C57BL/6 mice, the levels of IFN-gamma produced by Th1 cells were decreased while IL-4 production remained low. When TNF-matured DC were pretreated with PGD2, loaded with the endotoxin-free antigen KLH and injected s.c. into Th2-prone BALB/c mice, we found a dose- and time-dependent upregulation of IL-4 and downregulation of IFN-gamma by T cells. Together, MC-derived PGD2 instructs DC to polarize CD4+ T cells towards Th2 responses. As a consequence, such a DC-MC cooperation may contribute to the maintenance of Th2 responses in allergic patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920486     DOI: 10.1016/j.imbio.2006.05.020

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  26 in total

1.  Co-operative signalling through DP(1) and DP(2) prostanoid receptors is required to enhance leukotriene C(4) synthesis induced by prostaglandin D(2) in eosinophils.

Authors:  F P Mesquita-Santos; I Bakker-Abreu; T Luna-Gomes; P T Bozza; B L Diaz; C Bandeira-Melo
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

Review 2.  Immunomodulatory mast cells: negative, as well as positive, regulators of immunity.

Authors:  Stephen J Galli; Michele Grimbaldeston; Mindy Tsai
Journal:  Nat Rev Immunol       Date:  2008-06       Impact factor: 53.106

3.  Genetic deletion of mPGES-1 abolishes PGE2 production in murine dendritic cells and alters the cytokine profile, but does not affect maturation or migration.

Authors:  S U Monrad; F Kojima; M Kapoor; E L Kuan; S Sarkar; G J Randolph; L J Crofford
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2010-12-28       Impact factor: 4.006

4.  FcεRI, but not FcγR, signals induce prostaglandin D2 and E2 production from basophils.

Authors:  Tsukasa Ugajin; Takahiro Satoh; Toru Kanamori; Kosuke Aritake; Yoshihiro Urade; Hiroo Yokozeki
Journal:  Am J Pathol       Date:  2011-06-25       Impact factor: 4.307

Review 5.  Molecular biology of atopic dermatitis.

Authors:  Zhanglei Mu; Yan Zhao; Xiaojing Liu; Christopher Chang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

Review 6.  Prostanoid receptor antagonists: development strategies and therapeutic applications.

Authors:  R L Jones; M A Giembycz; D F Woodward
Journal:  Br J Pharmacol       Date:  2009-07-15       Impact factor: 8.739

Review 7.  Mast cells and immunological skin diseases.

Authors:  Daniel Navi; Jun Saegusa; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

Review 8.  The roles of the prostaglandin D(2) receptors DP(1) and CRTH2 in promoting allergic responses.

Authors:  R Pettipher
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

Review 9.  Mast cells: multitalented facilitators of protection against bacterial pathogens.

Authors:  Nikita H Trivedi; M Neal Guentzel; Annette R Rodriguez; Jieh-Juen Yu; Thomas G Forsthuber; Bernard P Arulanandam
Journal:  Expert Rev Clin Immunol       Date:  2013-02       Impact factor: 4.473

10.  5-hydroxytryptamine modulates migration, cytokine and chemokine release and T-cell priming capacity of dendritic cells in vitro and in vivo.

Authors:  Tobias Müller; Thorsten Dürk; Britta Blumenthal; Melanie Grimm; Sanja Cicko; Elisabeth Panther; Stephan Sorichter; Yared Herouy; Francesco Di Virgilio; Davide Ferrari; Johannes Norgauer; Marco Idzko
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.